Fig. 1From: A phase IIa proof-of-concept, placebo-controlled, randomized, double-blind, crossover, single-dose clinical trial of a new class of bronchodilator for acute asthmaStudy design from enrollment to analysis following the CONSORT guidelinesBack to article page